AU5654096A - Antisense peptides - Google Patents

Antisense peptides

Info

Publication number
AU5654096A
AU5654096A AU56540/96A AU5654096A AU5654096A AU 5654096 A AU5654096 A AU 5654096A AU 56540/96 A AU56540/96 A AU 56540/96A AU 5654096 A AU5654096 A AU 5654096A AU 5654096 A AU5654096 A AU 5654096A
Authority
AU
Australia
Prior art keywords
antisense peptides
antisense
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56540/96A
Inventor
Andrew David Miller
John Graham Raynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial College of Science Technology and Medicine
London School of Hygiene and Tropical Medicine
Original Assignee
Imperial College of Science Technology and Medicine
London School of Hygiene and Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9509263.1A external-priority patent/GB9509263D0/en
Priority claimed from GBGB9607505.6A external-priority patent/GB9607505D0/en
Application filed by Imperial College of Science Technology and Medicine, London School of Hygiene and Tropical Medicine filed Critical Imperial College of Science Technology and Medicine
Publication of AU5654096A publication Critical patent/AU5654096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU56540/96A 1995-05-05 1996-05-07 Antisense peptides Abandoned AU5654096A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9509263.1A GB9509263D0 (en) 1995-05-05 1995-05-05
GB9509263 1995-05-05
GBGB9607505.6A GB9607505D0 (en) 1996-04-11 1996-04-11
GB9607505 1996-04-11
PCT/GB1996/001082 WO1996034887A2 (en) 1995-05-05 1996-05-07 Antisense peptides

Publications (1)

Publication Number Publication Date
AU5654096A true AU5654096A (en) 1996-11-21

Family

ID=26306997

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56540/96A Abandoned AU5654096A (en) 1995-05-05 1996-05-07 Antisense peptides

Country Status (2)

Country Link
AU (1) AU5654096A (en)
WO (1) WO1996034887A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0866805A1 (en) 1995-12-12 1998-09-30 Karolinska Innovations AB PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
AU5254198A (en) * 1996-11-13 1998-06-03 Parkash S Gill Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists
US7060670B1 (en) 1999-05-05 2006-06-13 Neurochem (International) Limited Stereoselective antifibrillogenic peptides and peptidomimetics thereof
FR2825154B1 (en) * 2001-05-22 2004-01-30 Univ Compiegne Tech COMPOUNDS CAPABLE OF MODULATING ACTIVITY AND STIMULATING THE PRODUCTION OF A CATALYTIC ANTIBODY
TWI322690B (en) * 2006-05-11 2010-04-01 Flysun Dev Co Ltd Short interference ribonucleic acids for treating allergic dieases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1188550B (en) * 1986-02-07 1988-01-14 Sclavo Spa SYNTHETIC PEPTIDE WITH INTERLEUKINA 1 HUMAN ACTIVITY
US5039790A (en) * 1989-01-11 1991-08-13 Monsanto Company Bioactive fragment of interleukin-1-B that has antagonistic activity
DE69033395D1 (en) * 1989-07-31 2000-01-20 Tecnogen Scpa Process for the identification and production of binding sites of interacting proteins
WO1994009128A1 (en) * 1992-10-22 1994-04-28 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis

Also Published As

Publication number Publication date
WO1996034887A2 (en) 1996-11-07
WO1996034887A3 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
AU7203496A (en) Novel peptides
AU7286696A (en) Antisense oligomers
AU4766196A (en) Anti-obesity proteins
AU4774496A (en) Anti-obesity proteins
AU4862096A (en) Anti-obesity proteins
AU4705196A (en) Anti-obesity proteins
AU4774696A (en) Anti-obesity proteins
AU4766096A (en) Anti-obesity proteins
AU1030997A (en) Taphane
AU5181296A (en) Anti-obesity proteins
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU2131195A (en) Prophenins - antibiotic peptides
HUP9603537A2 (en) Peptides having immunmodulator influences
AU5989696A (en) Tcr vbeta5 peptides
AU4382896A (en) Acetylimidazobenzodiazepines
AU7520396A (en) Abl-interactor protein
AU1999999A (en) Contryphan peptides
AU5284296A (en) Immune-evading proteins
AU5654096A (en) Antisense peptides
AU6890696A (en) Peptide derivatives
AUPM489194A0 (en) Peptides
AU6890596A (en) Peptide derivatives
AU5161296A (en) Anti-haemorrhagic peptides
AU6153396A (en) E6ap-binding proteins